Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Journal of Gastrointestinal Oncology|April 2, 2016
The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimenMichael J McNamara, Lisa A Rybicki, Davendra Sohal, et al.Annals of Surgical Oncology|March 5, 2026
Key Updates on the Version 9 AJCC/UICC Staging System for Salivary Gland CarcinomaShao Hui Huang, Raja R Seethala, Snehal G Patel, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2017
Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant OutcomesBethany T Samuelson Bannow, Rachel B Salit, Barry E Storer, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junctionMichael J McNamara, David J Adelstein, Joanna W Bodmann, et al.Journal of Palliative Medicine|December 1, 2021
High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint InhibitorsCameron Chalker, Rafael Santana-Davila, Jenna M Voutsinas, et al.Telemedicine Reports|October 27, 2025
Feasibility of Intensive Multidisciplinary Telerehabilitation Combined with Health Coaching for Underserved Stroke Survivors: A Pilot StudyEmily A Stevens, Robert Suchting, Jane A Anderson, et al.Cancer Medicine|March 29, 2022
Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patientsCameron Chalker, Jenna M Voutsinas, Qian Vicky Wu, et al.Head & Neck|June 10, 2014
Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial designCristina P Rodriguez, David J Adelstein, Lisa A Rybicki, et al.Cancer Reports (Hoboken, N.J.)|February 5, 2025
Adjuvant Proton Beam Radiation Therapy for Sinonasal Mucosal MelanomaJamie S K Takayesu, Upendra Parvathaneni, George E Laramore, et al.Head & Neck|April 25, 2025
Dual PD-1 and CTLA4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland CancersCristina P Rodriguez, Qian Vicky Wu, Kevin Ng, et al.Pageof 8